EQT opts for mezz to back BSN buyout as high yield bonds struggle to compete
With Europe’s high yield market all but closed, mezzanine lenders underscored their product’s reliability and potential competitiveness this week by delivering €391.5m of junior debt for EQT’s leveraged buy-out of BSN Medical, write Olly West and Stefanie Linhardt.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
